Left atrial appendage occlusion should be offered only to select atrial fibrillation patients
- PMID: 36097461
- PMCID: PMC9463703
- DOI: 10.1016/j.hroo.2022.07.001
Left atrial appendage occlusion should be offered only to select atrial fibrillation patients
Keywords: Direct-acting oral anticoagulants; Heart failure; Kidney disease; Left atrial appendage occlusion; Oral anticoagulants; Subgroups; Women.
References
-
- Lloyd-Jones D.M., Wang T.J., Leip E.P., et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–1046. - PubMed
-
- Virani S.S., Alonso A., Benjamin E.J., et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596. - PubMed
-
- Saposnik G., Gladstone D., Raptis R., Hart R.G. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke. 2013;44:99–104. - PubMed
-
- Seet R.C., Zhang Y., Wijdicks E.F., Rabinstein A.A. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol. 2011;68:1454–1458. - PubMed
-
- Connolly S.J., Ezekowitz M.D., Yusuf S., et al. RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–1151. - PubMed
LinkOut - more resources
Full Text Sources
